In this study, C6 glioma cells were used to test the effects of 2-azafluorenone and its related compounds on membrane phosphatidylinositol (PI) and phosphatidylcholine (PC) turnover. An increase of 
Introduction
Azafluorenone derivatives were previously reported to possess aldose reductase inhibitor properties (7) . These compounds were also found to be structurally related to a significant class of alkaloids such as onychines (19) . A convenient method for the synthesis of 2-azafluorenone and other tricyclic pyridines by intramolecular cyclization of 4-arylpyridines was reported by Shiao et al. (15) . In addition, Hundsdorf et al. (7) reported a new and general synthesis procedure for substituted 2-azafluorenones for drug development purposes. Recently, Prachayasittikul et al. (13, 14) obtained bioactive azafluorenone alkaloids from the Polyalthia debilis (Pierre) Finet and Gagnep (Annonaceae) plants. They reported that the bioactive extracts of these plants have potential antimicrobial, antimalarial and cytotoxic activities. These findings suggest that potential uses of P. debilis in medicinal applications.
In order to seek further biological actions of these compounds as described in the above-mentioned reports and in our previous report (17) in which we used C6 glioma cells to test the effects of 2-azafluorenone and its related compounds on histamine-induced phosphatidylinositol (PI) turnover based on similarities in the chemical structures of these compounds (16) and histamine H1 receptor antagonists such as chlorpheniramine. In that study, 2-azafluorenones were found to inhibit [ 3 H]inositol phosphate ([ 3 H]IP 1 ) accumulation through activation by histamine, AlF4 -, ATP, bradykinin and A23187, a calcium ionophore. From the data of the mode of action study, the blocking effects of these compounds were found not on receptor, G-proteins or calcium channel molecules, but at the enzyme level of phosphatidyl inositol-specific phospholipase C (PI-PLC). Inhibition of PI-PLC enzyme resulted in a decrease of [ 3 H]IP 1 accumulation (17) . In this study, the specific action on PI-PLC, but not on other enzymes such as phosphatidyl choline (PC)-PLC or PCphospholipase D (PLD), was further investigated.
Materials and Methods
The radioisotope-labeled compounds, choline choloride [methyl-3 H]-HOCH2CH2 H (CH3)3.
. Cl (86.7 Ci/mmole) and [1, 2- 3 H]-L-myo-inositol (45.8 Ci/ mmole) used in this study were purchased from New England Nuclear (Boston, MA, USA). Histamine HCl, chlorpheniramine, 3, 4, 5-tri-methoxy-benzoic acid 8-(diethyl amino) octylester (TMB-8), A23187, choline (chloride salt), phosphatidylcholine chloride (calcium salt), sodium fluoride and aluminium chloride were purchased from Sigma Chemicals (St. Louis, MO, USA). Ready Safe Liquid Scintillation Cocktail was obtained from Beckman (Fullerton, CA, USA) for sample counting in Beckman LS-3801 model. Cation Counter (Spex Model CMIT 111) was used in this study.
Cell Culture
The C6 glioma cell line was a gift from Professor of T. T. Chou of the Institute of Neuroscience, National Yang Ming University. These cells were cultured in Ham's F-10 medium (J.R.H. Bio-Science, Lenexa, KS, USA) with 10% fetal bovine serum (Hyclone, Logan, UT, USA). Cells in T-75 flasks were kept at 37°C, 5% CO 2 and 95% O 2 in an incubator. The culture medium was changed every other day. This cell line has been used widely for decades since its establishment in 1968 (1) . Although it has been cultured extensively in vitro, its tumorigenecity remains quite stable (21) .
Methods for Cell Growth in Experiments
C6 glioma cells were seeded on three glass cover slips (10 × 40 mm) and kept in a 60-mm culture flask; the flask was then kept in a humidified incubator at 37°C and 5% CO 2 until cell growth reached confluency. Before experiment, the medium was changed to F-10 culture medium without bovine serum. Labeled materials were added to each flask for a defined period of time, and the unlabeled portion was washed out three times with TM buffer (50 mM TrisHCl, 0.5 mM MgCl 2 , pH 7.5). (2, 11) [
Phosphatidylinositol (PI) Turnover Analysis
3 H]-labeled myo-inositol (1 µCi/ml) was added into each flask for a 24-h incubation period, and the culture medium was then removed. The cells were washed three times with TM buffer. LiCl (10 mM) was then added to prevent the break down of inositol phosphates into inositol. After that, a stimulator such as histamine was added into the flask for a defined period of time. At the end of the incubation, an icecold TM buffer was used to wash cells twice to terminate reaction. The glass plates were removed for counting and kept in scintillation counting vials. Subsequently, extraction of phospho-inositol metabolites was carried out. An amount of 2.4 ml chloroform/ methanol mixture (1:2) (v/v) was added to the scintillation vials, which contained the C6 glioma cells. At the end of the PI turnover reaction, the vials were vortexed vigorously for 30 sec to extract [ 3 H]IP 1 from the cells. Chloroform (0.8 ml) and 0.8 ml of double-distilled water were added and stirred thoroughly for 15 sec. The scintillation vials were kept and shaken in a sonicator for 15 min to remove the cells from the glass plates. After centrifugation at 500 g for 10 min to separate the solution into a top aqueous and a bottom chloroform layers, 200 µl was removed from the chloroform layer to scintillation vials in which 3 ml liquid scintillation cocktail was added. After mixing, the vials were counted to determine [ 3 H]inositol incorporation.
Analysis of GPI and PI (11)
PI was analyzed by anion-exchange chromatography. Half milliliter AGI × 8 resin (100-200 mesh, formate form) was kept in a Pasteur pipette to form a column. Diluted aqueous extraction material was added (6.4 ml) into the column and the PI was combined with resin. Ten ml of double-distilled water was added to wash out free PI. Then 6 ml 60 mM sodium formate and 5 ml sodium tetraborate were added to wash the
, and the first 2 ml was collected in a scintillation vial. Finally 2 ml 0.2 M ammonium formate/0.1 M formic acid solution was added to wash out the [ 3 H]IP 1 which was collected in scintillation vials, then mixed well with 6 ml of Effects of 2-Azafluorenones on PI-PLC, but not on PC-PLC or PC-PLD-Activation 13 scintillation fluid for scintillation counting.
Phosphatidylcholine Turnover Study
In this study, the method of Yavin (20) Finally, 1 ml extracellular medium was removed for measuring the extracellular choline metabolites released. Then cells were washed 3 times with cold TM buffer to stop the reaction: the cover glass slips were removed and kept in scintillation counting vials, and extraction of extracellular choline metabolites released by these cells were carried out. Extracellular choline release measurement: One ml extracellular fluid was centrifuged at 200 g for 10 min to let cells settle. Supernatant (0.5 ml) was removed and kept in a scintillation vial. One and a half ml of scintillation fluid was added and mixed well for counting of extracellular choline metabolites.
Extraction of intracellular phosphocholine and intracellular choline released: Three ml chloroform/ methanol (2/1; v/v) was added to scintillation vials which contained glass cover slips. After vigorous mixing for 30 seconds, 1 ml of double-distilled water was added, and then stirred for 15 sec followed by ultrasonic vibration for 15 min to remove the cells from the glass slips. These vials were then centrifuged at 500 g for 10 min, and the fluid was separated into 2 layers: upper aqueous and lower chloroform phases. Aliquots of 1.6 ml aqueous solution were removed into test tubes and kept in a 60°C oven for drying. Intracellular choline and intracellular phosphocholine in these cells in these samples were analyzed by using thin layer chromatography (TLC) as reported by Martinson et al. (10) .
Statistical Analysis
In this study, Student's t-test was used for statistical analysis; the significant difference was set as P < 0.05 between two groups in the comparison. Each experiment was carried out in triplicates, and each test was repeated at least three times.
Results

Study of Intracellular [ 3 H] IP 1 Accumulation Induced by Histamine or A23187
Histamine, but not platelet activating factor (PAF), interacting with its histamine H 1 receptors located on the cell membrane via G-protein linkage mediates the activation of the enzyme PI-PLC. Activation of this enzyme can break down membrane phospholipid of PI into products of diacylglycerol (DG) and inositol phosphates. Besides, A23187, a calcium ionophore, can also activate this PI-PLC enzyme (5, 17) . In this study, histamine (from 10 -7 to 10 -3 M) caused a concentration-dependent increase of [ 3 H]IP 1 accumulation, whereas PAF did not have such an effect from 0.2 to 1.0 µM (Fig. 1 ). Histamine at a concentration of 100 µM caused an increase of [ 3 H]IP 1 formation which could be blocked by 2-azafluorenones F1 to F4 (Fig. 2) . Besides, compound A23187 at 1 µM also induced an increase of [ 3 H]IP 1 formation, and this increase was inhibited by 2-azafluorenones (Fig. 3) .
Study of Extracellular [ 3 H]Choline Metabolites Accumulation Induced by PAF
PAF, but not histamine, interacting with its PAF receptors located on the cell membrane via G-protein linkage causes the activation of enzyme PC-PLD. Activation of this enzyme can degrade PC into products of phosphatidic acid (PA), and choline (6, 9). LiCl, and the cultures were exposed to various concentrations of histamine and PAF for 60 min. The basal level measured in the absence of histamine was 3216.7 ± 52.4 dpm/10 7 cells. The data presented are the means ± S.E.M. from five independent experiments, which were performed in triplicates. *The value was significant difference comparing with that of control (P < 0.05). Here, we showed that PAF caused a concentrationdependent (from 2 to 10 × 100 nM) increase of extracellular [ 3 H]choline metabolites, whereas histamine did not cause such an effect from 10 -7 to 10 -3 M concentrations (Fig. 4) .
Effects of 2-Azafluorenone (F1) and 4-Methyl-2-Azafluorenone (F2) on PAF, PMA and A23187 Stimulated [ 3 H]-Labeled Extracellular Choline Metabolites Accumulation
Both F1 and F2 at 100 µM did not significant effects on PAF (1 µM)-, PMA (10 nM)-and A23187 (100 nM)-induced enhancing effect (Fig. 5) .
Study of Intracellular [ 3 H]-Labeled Phosphocholine Accumulation Induced by PAF
PAF caused a concentration-dependent (0.2 to 1.0 M) increase of intracellular [ 3 H]phosphocholine accumulation, whereas histamine did not cause such an effect from 10 -7 to 10 -3 M (Fig. 6) .
Effects of F1 and F2 on PAF, PMA and A23187-Stimulated [ 3 H]-Labeled Intracellular Phosphocholine and Choline Accumulation
PMA and A23187 can elicit enzyme PC-PLC activation, which is located at cell membrane to break down phosphatidylcholine (PC) into products of DG, and phosphocholine (p-choline) (12, 18) . Our results showed that both F1 and F2 at 100 µM did not have any significant effects on PAF (1 µM)-, PMA (10 nM)-and A23187 (100 nM)-induced enhancing effect (Fig. 7) . On the other hand, both F1 and F2 at 100 µM did not have any significant effect on PMA-and A23187-induced enhancing effect (Fig. 8) .
Discussion
In this study, the data showed that histamine increased [ 3 H]inositol phosphate formation via the activation of PLC to breakdown labeled substrate. This effect could be blocked by 2-azafluorenone and 4-methyl 2-azafluorenone in a dose and a timedependent manner; this inhibitory effect was also found in chemically related compound of 6-cholo 2-azafluorenone and 6-methoxy-2-azafluorenone. A23187 also induced an increase in [ 3 H]IP 1 accumulation via activation on PI-PLC to breakdown the labeled ]inositol-labeled cells were preincubated with 100 µM of various compounds from F1 to F4 which are chemically related to 2-azafluorenones for 10 min, and then incubated for a further 60 min with 100 µM histamine in the presence of 10 mM LiCl. Results are expressed as percentage of the histamine-stimulated response (41216 ± 1321 dpm/10 7 cells at 100 µM of histamine) as 100% in unpretreated cultures whereas the basal level was measured in the absence of histamine (3217 ± 50 dpm/10 7 cells) as 0%. The data were presented as the means ± S.E.M. from three independent experiments. F1, 2-azafluorenone, F2, 4-methyl 2-azafluorenone, F3, 6-cholo 2-azafluorenone, F4, 6-methoxy 2-azafluorenone. *Significant effects of 2-azafluorenones treatment on histamine response when compared the value with that of histamine only (based on Student's t-test; P < 0.05). ]Choline-labeled cells were incubated with 10 mM LiCl, the cultures were then exposed to various concentrations of histamine and PAF for 60 min. The basal level measured in the absence of histamine and PAF was 14361 ± 1759 dpm/10 7 cells. The data presented are the means ± S.E.M. from five independent experiments, which were performed in triplicate. *The value was significant difference comparing with that of control (P < 0.05). cells. The data presented are the means ± S.E.M. from five independent experiments, which were performed in triplicates. *The value was significant difference comparing with that of control (P < 0.05). Because these products of PI-PLC activation are important not only in normal cell physiology but also in pathologic processes, the potential of PI-PLCdependent processes as drug target has recently received increasing attention (3). Indeed, the possible therapeutic uses of PI-PLC inhibitors are as diverse as the various cellular functions of PI-PLC that have been identified. For example, selective inhibitors of PI-PLC, such as U73122 or ET-18-OCH3, have been tested on antinociception (4). Besides, PI-PLC is an attractive target for pharmacological intervention in a number of human diseases, particularly those related to abnormal cell proliferation such as cancer (8) . In this study, 2-azafluorenones were also found to exert selective inhibition on PI-PLC, but not on PC-PLC or PC-PLD enzyme moiety; as an enzyme inhibitor, this is an important finding for these potential candidates. Further chemical and biological studies on this category of compounds are needed before the drug development process.
In summary, based on changes of enzyme products, the inhibitory effect of 2-azafluorenone and its related compound 4-methyl 2-azafluorenone is shown to mainly act on PI-PLC, but not on PC-PLC or PC-PLD enzyme moiety.
